Erasca Correlations

ERAS Stock  USD 3.28  0.01  0.31%   
The current 90-days correlation between Erasca Inc and Keros Therapeutics is 0.32 (i.e., Weak diversification). The correlation of Erasca is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Erasca Correlation With Market

Significant diversification

The correlation between Erasca Inc and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Erasca Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Moving together with Erasca Stock

  0.73PFE Pfizer Inc Earnings Call This WeekPairCorr
  0.61ANIK Anika TherapeuticsPairCorr
  0.82IRMD Iradimed Earnings Call This WeekPairCorr
  0.61ITGR Integer Holdings CorpPairCorr
  0.69OFIX Orthofix MedicalPairCorr
  0.84SGHT Sight Sciences Earnings Call This WeekPairCorr
  0.75AAC AAC HoldingsPairCorr
  0.7MDH MDH Acquisition CorpPairCorr
  0.78APAC Stonebridge Acquisition Symbol ChangePairCorr
  0.76ARTE Artemis StrategicPairCorr
  0.66TRCA Twin Ridge CapitalPairCorr

Moving against Erasca Stock

  0.62ALVO AlvotechPairCorr
  0.54ONCT Oncternal TherapeuticsPairCorr
  0.51MRK Merck Company Earnings Call This WeekPairCorr
  0.51IMMP Immutep Ltd ADR Earnings Call This WeekPairCorr
  0.5ENTX Entera BioPairCorr
  0.49TARA Protara Therapeutics Earnings Call This WeekPairCorr
  0.47ATHE Alterity TherapeuticsPairCorr
  0.35NPCE NeuropacePairCorr
  0.63CVI CVR Energy Earnings Call This WeekPairCorr
  0.56LION Lionsgate Studios CorpPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
GLUEKROS
CCCCGLUE
CCCCKROS
MLYSEWTX
MLYSDSGN
CCCCDSGN
  
High negative correlations   
GRCLGLUE
GRCLKROS
CCCCGRCL
THRXGRCL
GRCLIPSC
EWTXIPSC

Risk-Adjusted Indicators

There is a big difference between Erasca Stock performing well and Erasca Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Erasca's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
IPSC  4.56 (0.20) 0.00  2.17  0.00 
 11.11 
 30.97 
NGM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
KROS  2.28 (0.15) 0.00 (0.03) 0.00 
 6.08 
 16.46 
GLUE  4.01 (0.29) 0.00 (0.07) 0.00 
 8.36 
 24.79 
GRCL  5.71  1.36  0.19  1.73  6.35 
 16.34 
 52.11 
THRX  5.44 (0.75) 0.00 (0.20) 0.00 
 11.75 
 90.33 
DSGN  3.58  0.62  0.16  0.70  3.30 
 8.19 
 37.04 
EWTX  2.99  0.39  0.08  3.92  3.64 
 6.29 
 15.05 
CCCC  3.73 (0.19)(0.01) 0.01  4.34 
 11.08 
 23.76 
MLYS  2.45  0.21  0.07  0.27  2.80 
 4.90 
 16.39 

Erasca Corporate Management

Esq JDGeneral SecretaryProfile
Michael VarneyScientific DevelopmentProfile
Chandra LovejoyVP AffairsProfile
Lisa TesvichBonoraChief OfficerProfile
Nik ChetwynVP OperationsProfile
CPA MSVP FinProfile
Wei MDChief OfficerProfile